Article
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.
The Journal of biological chemistry - 3 Apr 1998
Kemball-Cook G, Johnson D J, Takamiya O, Banner D W, McVey J H, Tuddenham E G
Abstract excerpt
We have used recombinant mammalian expression and purification of the factor VII (FVII) variant Gln100 --> Arg (Q100RFVII) to study FVII deficiency in subjects with this mutation. Q100RFVII was secreted poorly in comparison with wild-type FVII (WTFVII) in a stable mammalian expression system, and purified variant protein was found to have undetectable clotting activity. Following activation by immobilized factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
